Petrus Järvinen

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Renal Cell Carcinoma

Ejection Fraction

Prostate Cancer

Top Venues

Scandinavian journal of urology

Scientific reports

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Moon Hee Lee, Jason Theodoropoulos, Jani Huuhtanen, Dipabarna Bhattacharya, Petrus Järvinen, Sara Tornberg, Harry Nísen, Tuomas K Mirtti, Ilona Uski, Anita Kumari, Karita Peltonen, Arianna Draghi, Marco Donia, Anna Kreutzman, Mohamed El Missiry
Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma. Cancer research communications 3 (7) (2023)
Moon Hee Lee, Petrus Järvinen, Harry Nísen, Oscar Brück, Mette Ilander, Ilona Uski, Jason Theodoropoulos, Matti Kankainen, Tuomas K Mirtti, Mohamed El Missiry, Anna Kreutzman
T and NK cell abundance defines two distinct subgroups of renal cell carcinoma. Oncoimmunology 11 (1) (2022)
Lassi Luomala, Juhana Rautiola, Petrus Järvinen, Tuomas K Mirtti, Harry Nísen
Active surveillance versus initial surgery in the long-term management of Bosniak IIF-IV cystic renal masses. Scientific reports 12 (1) (2022)
Sara V Tornberg, Harry Nisen, Petrus Järvinen, Riikka Järvinen, Tuomas P Kilpeläinen, Kimmo Taari, Ulf-Håkan Stenman, Harri Visapää
Serum tumour associated trypsin inhibitor, as a biomarker for survival in renal cell carcinoma. Scandinavian journal of urology 54 (5) (2020)
Victor Cervera-Carrascon, Dafne C A Quixabeira, Joao Manuel Santos, Riikka Havunen, Sadia Zafar, Otto Hemminki, Camilla Heiniö, Eleonora Munaro, Mikko Siurala, Suvi Sorsa, Tuomas K Mirtti, Petrus Järvinen, Markus Mildh, Harry Nisen, Antti Sakari Rannikko, Marjukka Anttila, Anna Kanerva, Akseli Hemminki
Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition. Oncoimmunology 9 (1) (2020)